Pfizer Ups Stock Buyback to $10 Billion

Health and Healthcare

Published: June 28, 2013 3:41 am

Last Updated: June 28, 2013 6:19 am

In a sign that Pfizer Inc. (NYSE: PFE) has more cash on hand than the sense to use it wisely to create new drugs, its board approved a $10 billion share buyback. Pfizer has effectively cut costs, some via layoffs. R&D on new treatments is critical to the pharma company in a world of new age medicines, biotech and generics. Nonetheless, Pfizer believes it can increase shareholder returns by delivering cash the way that other public corporations like McDonald’s Corp. (NYSE: MCD) do. But a pharma company is not a fast-food chain.

The company announced:

The board of directors of Pfizer Inc. today declared a 24-cent third-quarter 2013 dividend on the company’s common stock, payable September 4, 2013, to shareholders of record at the close of business on August 2, 2013. The third-quarter 2013 cash dividend will be the 299th consecutive quarterly dividend paid by Pfizer.

In addition, the board of directors has authorized a new $10 billion share repurchase program to be utilized over time. This new program is in addition to the $3.9 billion of authorization remaining under the company’s current share repurchase program.

Are You Ahead, or Behind on Retirement? (sponsor)

If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention.

Finding a financial advisor who puts your interest first can be the difference between a rich retirement and barely getting by, and today it’s easier than ever. SmartAsset’s free tool matches you with up to three fiduciary financial advisors that serve your area in minutes. Each advisor has been carefully vetted, and must act in your best interests. Start your search now.

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.